PBMS UNDER THE MICROSCOPE
Washington,
June 21, 2022
PBMS UNDER THE MICROSCOPE — Members of the House Committee on Education and Labor have requested that the Government Accountability Office conduct a study on pharmacy benefit managers, citing concerns about their role in drug pricing. In a letter shared with Pulse, lawmakers asked the GAO to look into PBMs’ services to commercial health plans and how they are reimbursed, the use and effect of PBM formularies and rebating arrangements on commercial drug spending on payers and beneficiaries, and what role the Employee Retirement Income Security Act’s fiduciary requirements have in the services PBMs provide to commercial plans.
|
